At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AMRN Amarin Corp PLC
Trading 04-08 09:42:57 EDT
14.99
+0.30
+2.04%
High14.99Low14.95Vol2.33K
Open14.95D1 Closing14.69Amplitude0.27%
Mkt Cap311.68MTradable Cap281.15MTotal Shares20.79M
T/O34.82KT/O Rate0.01%Tradable Shares18.76M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

BUZZ-Amarin rises as heart drug spotlighted at major cardiology meet
Reuters  ·  46 minutes ago
BUZZ-Amarin rises as heart drug spotlighted at major cardiology meet
Amarin says REDUCE-IT post hoc analysis shows Vascepa cuts events in highest-risk patients
Reuters  ·  20:04
Amarin says REDUCE-IT post hoc analysis shows Vascepa cuts events in highest-risk patients
American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction
GlobeNewswire  ·  20:00
American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
MT Newswires Live  ·  03-30
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
Amarin board shrinks to seven directors; Paul Cohen and Oliver O'Connor exit ahead of 2026 annual meeting
Reuters  ·  03-28
Amarin board shrinks to seven directors; Paul Cohen and Oliver O'Connor exit ahead of 2026 annual meeting
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
MT Newswires Live  ·  03-24
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
MT Newswires Live  ·  03-19
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
Amarin cites 2026 ACC/AHA dyslipidemia guideline support for icosapent ethyl in statin-treated patients with elevated triglycerides
Reuters  ·  03-18
Amarin cites 2026 ACC/AHA dyslipidemia guideline support for icosapent ethyl in statin-treated patients with elevated triglycerides
Amarin to present new REDUCE-IT subgroup analysis of icosapent ethyl at ACC 2026
Reuters  ·  03-16
Amarin to present new REDUCE-IT subgroup analysis of icosapent ethyl at ACC 2026
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
GlobeNewswire  ·  03-16
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk
TIPRANKS  ·  03-04
Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk
Amarin post hoc REDUCE-IT analysis links icosapent ethyl to fewer hospitalizations and fewer days lost to hospitalization and death
Reuters  ·  03-02
Amarin post hoc REDUCE-IT analysis links icosapent ethyl to fewer hospitalizations and fewer days lost to hospitalization and death
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology
GlobeNewswire  ·  03-02
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amarin (AMRN), Ionis Pharmaceuticals (IONS) and Repligen (RGEN)
TIPRANKS  ·  02-26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amarin (AMRN), Ionis Pharmaceuticals (IONS) and Repligen (RGEN)
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT Newswires Live  ·  02-26
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Rpt-Amarin Reports Fourth Quarter and Full Year 2025 Financial Results
THOMSON REUTERS  ·  02-25
Rpt-Amarin Reports Fourth Quarter and Full Year 2025 Financial Results
Corrected-Amarin Q4 Revenue (Not 'Product REV') USD 49.2 Million
THOMSON REUTERS  ·  02-25
Corrected-Amarin Q4 Revenue (Not 'Product REV') USD 49.2 Million
Amarin CFO says ‘well positioned’ to deliver on 2026 strategic priorities
TIPRANKS  ·  02-25
Amarin CFO says ‘well positioned’ to deliver on 2026 strategic priorities
Amarin Q4 net loss narrows to USD 1.2 million (97%)
Reuters  ·  02-25
Amarin Q4 net loss narrows to USD 1.2 million (97%)
Amarin Corp Q4 Adj. EPS $0.01 Beats $(0.56) Estimate, Sales $49.219M Miss $50.619M Estimate
Benzinga  ·  02-25
Amarin Corp Q4 Adj. EPS $0.01 Beats $(0.56) Estimate, Sales $49.219M Miss $50.619M Estimate

Introduction

Company Name.
Amarin Corp PLC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Issue price:
--